Patients received cardiac surgery for coronary artely disease or cardiac valvular disease
Conditions
Interventions
Patients who have standard medical therapy receive Waon therapy once a day for two weeks starting from one week after cardiac surgery
Patients who receive standard medical therapy without Waon therapy
Sponsors
The second department of internal medicine, university of Toyama
The first department of surgery, university of Toyama
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who receive cardiac surgery due to coronary artery desease or valvular heart desease
Exclusion criteria
Exclusion criteria: . Hemodynamically unstable . Serious infection . Prior stroke (within 3 months) . Anemia (hemoglobin<8g/dl) . Malignancy . Hematological disorder . Pregnancy . End stage renal desease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 6-minute walk distance before and after two-week Waon therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life score and cardiac function assesed by neurohumoral factors and echo cardiography | — |
Countries
Japan
Contacts
Public ContactTakashi Nozawa
University of Toyama The second department of internal medicine
Outcome results
None listed